Affordable Access

Publisher Website

Conjugation of metallothionein to a murine monoclonal antibody

Elsevier Inc.
Publication Date
DOI: 10.1016/0003-2697(88)90406-x
  • Monoclonal Antibodies
  • Metalloproteins
  • Immunochemical Techniques
  • Organic Synthesis
  • Radioactive And Cancer Chemotherapy
  • Biology
  • Medicine


Abstract A method of conjugation of the metal-binding protein, metallothionein, to an anticarcinoma murine monoclonal antibody, B72.3, and its F(ab′) 2 fragment has been developed utilizing the heterobifunctional crosslinking reagent, succinimidyl 4-( N-maleimidomethyl)-cyclohexane 1-carboxylate. This crosslinking reagent is first reacted with the free amines on the immunoglobulin. After removal of unreacted crosslinker, conjugation is affected through a sulfhydryl group on metallothionein. Under the conditions employed all immunoglobulin aggregates contained metallothionein. The degree of undesired aggregation is directly proportional to the number of metallothioneins attached to the immunoglobulin. This aggregation can be controlled by the amount of crosslinker and metallothionein presented to the immunoglobulin. The immunoglobulin conjugate retains full immunoreactivity and can be readily purified from the unreacted metallothionein and high molecular weight aggregates. The metallothionein-B72.3 conjugate functions as an efficient and stable chelator of radiometals. Thus metallothionein-monoclonal antibody conjugates have potential utility in cancer diagnosis and therapy.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Conjugation of metallothionein to a murine monoclo...

on Analytical Biochemistry July 1988

Antigenic determinants on rat metallothionein: fin...

on Journal of biochemistry April 1990

Efficient conjugation of DTPA to an IgM monoclonal...

on International Journal of Radia... 1988

Efficient conjugation of DTPA to an IgM monoclonal...

on International Journal of Radia... Jan 01, 1988
More articles like this..